US President backs investment in innovation, despite domestic spending freeze

27 January 2011

In his State of the Union Address on Tuesday evening, US President Barack Obama called for sweeping bipartisan investment in innovation, education and infrastructure to maintain the country's competitive edge, while at the same time proposing an annual domestic spending freeze for the next five years, which he said would reduce the USA’s deficit by more than $400 billion over the next decade.

"We need to out-innovate, out-educate, and out-build the rest of the world," said Pres Obama, adding "that's how we'll win the future."

He laid out his vision in a three-step effort that includes investment in spurring innovation, reform and investment in education and rebuilding out-dated infrastructure. In innovation, Pres Obama said maintaining leadership in research and technology is crucial to the country.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical